pLX304-ERBB2 Citations (1)
Originally described in: A germline ERBB3 variant is a candidate for predisposition to erythroid MDS/erythroleukemia.Braunstein EM, Li R, Sobreira N, Marosy B, Hetrick K, Doheny K, Gocke CD, Valle D, Brodsky RA, Cheng L Leukemia. 2016 Nov;30(11):2242-2245. doi: 10.1038/leu.2016.173. Epub 2016 Jun 15. PubMed Journal
Articles Citing pLX304-ERBB2
Articles |
---|
Intratumour oxidative hotspots provide a niche for cancer cell dissemination. Ueda Y, Kiyonaka S, Selfors LM, Inoue K, Harada H, Doura T, Onuma K, Uchiyama M, Kurogi R, Yamada Y, Sun JH, Sakaguchi R, Tado Y, Omatsu H, Suzuki H, Aoun M, Nakayama T, Kajimoto T, Yano T, Holmdahl R, Hamachi I, Inoue M, Mori Y, Takahashi N. Nat Cell Biol. 2025 Mar;27(3):530-543. doi: 10.1038/s41556-025-01617-w. Epub 2025 Feb 21. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.